LIGAND PHARMACEUTICALS INCORPORATED: capex
| Value | {"amount": 116000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2011-01-01 – 2011-09-30 |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:53:32.930900+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a507fb96-9a42-4fe5-b614-41b49c714360
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000886163-12-000060Retrieved: 2026-08-19T08:53:32.930900+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/capex/2011-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a507fb96-9a42-4fe5-b614-41b49c714360
History
- no predecessors — first report